Literature DB >> 3145259

Glidobactins D, E, F, G and H; minor components of the antitumor antibiotic glidobactin.

M Oka1, H Ohkuma, H Kamei, M Konishi, T Oki, H Kawaguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3145259     DOI： 10.7164/antibiotics.41.1906

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Improvement of glidobactin A production by Polyangium brachysporum.

Authors:  J A Titus; C A Roundy
Journal:  J Ind Microbiol       Date:  1990-11

2.  Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo.

Authors:  Marquicia R Pierce; Reeder M Robinson; Tannya R Ibarra-Rivera; Michael C Pirrung; Nathan G Dolloff; André S Bachmann
Journal:  Leuk Res       Date:  2019-11-12       Impact factor: 3.156

3.  Production of proteasome inhibitor syringolin A by the endophyte Rhizobium sp. strain AP16.

Authors:  Alexey Dudnik; Laurent Bigler; Robert Dudler
Journal:  Appl Environ Microbiol       Date:  2014-04-11       Impact factor: 4.792

4.  Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A.

Authors:  Roger G Linington; Benjamin R Clark; Erin E Trimble; Alejandro Almanza; Luis-David Ureña; Dennis E Kyle; William H Gerwick
Journal:  J Nat Prod       Date:  2009-01       Impact factor: 4.050

5.  Genome comparisons provide insights into the role of secondary metabolites in the pathogenic phase of the Photorhabdus life cycle.

Authors:  Nicholas J Tobias; Bagdevi Mishra; Deepak K Gupta; Rahul Sharma; Marco Thines; Timothy P Stinear; Helge B Bode
Journal:  BMC Genomics       Date:  2016-08-03       Impact factor: 3.969

6.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

Review 7.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.